Get started
Author

Sayantan Mitra

ORCID: 0000-0002-2419-0449
Observed ORCID: 0000-0002-2419-0449
OpenAlex ID: A5101408104
961 CX-908, a PROBODY ® T cell engager targeting CDH3 and CD3, induces tumor regressions and improves the therapeutic window in preclinical studies
2025 · Erwan Le Scolan, Lauren Kadavy, et al. · Journal for ImmunoTherapy of Cancer · 1
PDF
Partners in surviving: Holistic care for breast cancer survivors and caregivers
2023 · Hiba Siddiqui, Shraddha Namjoshi, et al. · Cancer Research Statistics and Treatment
Unmet Needs of Oral Cancer Survivors in India: A Perspective
2023 · Sayantan Mitra · Indian Journal of Medical and Paediatric Oncology
PDF
Data from Targeted Delivery of Paclitaxel to EphA2-Expressing Cancer Cells
2023 · Si Wang, Roberta Noberini, et al.
Works count: 4
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type